Holen Sie sich die Stockscreener-App
1.535
0.32%
-0.005
Handel nachbörslich:
1.52
-0.015
-0.98%
Schlusskurs vom Vortag:
$1.54
Offen:
$1.55
24-Stunden-Volumen:
87,321
Relative Volume:
0.08
Marktkapitalisierung:
$5.53M
Einnahmen:
$418.20K
Nettoeinkommen (Verlust:
$-46.90M
KGV:
-0.0635
EPS:
-24.1892
Netto-Cashflow:
$-29.84M
1W Leistung:
-9.71%
1M Leistung:
-62.11%
6M Leistung:
-64.22%
1J Leistung:
-87.42%
1-Tages-Spanne:
$1.52
$1.60
1-Wochen-Bereich:
$1.45
$1.9175
52-Wochen-Spanne:
$1.45
$3.95
Co Diagnostics Inc Stock (CODX) Company Profile
Firmenname
Co Diagnostics Inc
Sektor
Branche
Telefon
(801) 438-1036
Adresse
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
1.535 | 5.55M | 418.20K | -46.90M | -29.84M | -24.19 |
ABT
Abbott Laboratories
|
102.30 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.30 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.28 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.59 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.19 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-12 | Herabstufung | Sidoti | Buy → Neutral |
| 2021-12-29 | Eingeleitet | Sidoti | Buy |
| 2021-03-29 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-05-20 | Hochstufung | Maxim Group | Hold → Buy |
| 2020-05-18 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
Co Diagnostics Inc Aktie (CODX) Neueste Nachrichten
COVID-19 Detection Kits Market Set to Boom Rapidly by 2033 | - openPR.com
Co-Diagnostics, Inc. (CODX) stock price, news, quote and history - uk.finance.yahoo.com
Q4 2025 Co-Diagnostics Inc Earnings Call Transcript - gurufocus.com
Co-Diagnostics Joint Venture to Build Molecular Diagnostics Facility in Saudi Arabia - Clinical Lab Products
Co-Diagnostics, Inc.'s joint venture Comira has officially received approval to establish a manufacturing facility in Sudair Industrial City, Kingdom of Saudi Arabia. - Bitget
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City - The Herald Journal
Saudi Arabia clears industrial site for local molecular testing plant - Stock Titan
Co-Diagnostics reports operating loss of USD 50.2M in 2025 - Medical Buyer
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2025 Earnings Call Transcript - Insider Monkey
This diagnostics company is advancing a global expansion strategy, positioning for growth phase - MSN
Co-Diagnostics Expands South Asia Footprint, Targeting $13B Diagnostics Opportunity - USA Today
Exclusive: Co-Diagnostics ships diagnostic tests to India ahead of TB study launch - MSN
Co-Diagnostics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Stra - gurufocus.com
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... By GuruFocus - Investing.com Canada
Co-Diagnostics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Co-Diagnostics Q4 2025 sees mixed results, stock up 12% - Investing.com India
Co-Diagnostics Reports Full Year 2025 Financial Results - gurufocus.com
Earnings call transcript: Co-Diagnostics Q4 2025 sees mixed results, stock up 12% By Investing.com - Investing.com South Africa
CODX: Revenue fell, losses widened, but global expansion and regulatory progress drive future growth - TradingView
This Diagnostics Company Is Advancing a Global Expansion Strategy, Positioning for Growth Phase - The Globe and Mail
CODX: Revenue fell, but global expansion and clinical progress set the stage for future growth - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Co-Diagnostics (CODX) Releases Q4 2025 Earnings: Revenue Down, Net Loss Widens - Quiver Quantitative
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Co-Diagnostics (NASDAQ: CODX) warns on going concern while advancing PCR platform - Stock Titan
Co-Diagnostics (NASDAQ: CODX) 2025 revenue plunges as cash declines - Stock Titan
Co-Diagnostics Q4 2025 earnings preview - MSN
Exclusive: Co-Diagnostics expands South Asia reach, targets $13 billion market opportunity - msn.com
FRA:C970 PB Ratio: 0.24 — 86% Below Median - GuruFocus
Co-Diagnostics Inc expected to post a loss of $3.60 a shareEarnings Preview - TradingView
Q2 2025 Co-Diagnostics Inc Earnings Call Transcript - gurufocus.com
EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch - Sahm
Co-Diagnostics ships TB testing materials to India for studies By Investing.com - Investing.com South Africa
Q3 2025 Co-Diagnostics Inc Earnings Call Transcript - gurufocus.com
CODX Technical Analysis | Trend, Signals & Chart Patterns | CO-DIAGNOSTICS INC (NASDAQ:CODX) - ChartMill
Co-Diagnostics ships TB testing materials to India for studies - Investing.com India
Co-Diagnostics Ships Diagnostic Materials to India for Initiatio - GuruFocus
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization – Company AnnouncementFT.com - Financial Times
Recap Report: Should I set a stop loss on Co Diagnostics IncWeekly Trend Recap & Expert Approved Trade Ideas - baoquankhu1.vn
Co-Diagnostics expands commercial and distribution territory across South Asia - BioSpectrum Asia
Co-Diagnostics and CoSara expand distribution across South Asia - Yahoo Finance
EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity - AOL.com
Co-Diagnostics (NASDAQ: CODX) Expands CoSara Distribution Territory Across South Asia - The Globe and Mail
Dow Falls Over 100 Points; FedEx Posts Upbeat Earnings - Sahm
Chart Watch: What analysts say about Co Diagnostics Inc stockTrend Reversal & Low Drawdown Momentum Ideas - baoquankhu1.vn
Nasdaq Down Over 1%; XPeng Shares Fall After Q4 Results - Sahm
Finanzdaten der Co Diagnostics Inc-Aktie (CODX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):